Company Filing History:
Years Active: 2016
Title: Mark Albrecht: Innovator in Nucleic Acid Constructs
Introduction
Mark Albrecht is a notable inventor based in Washington, DC. He has made significant contributions to the field of biotechnology, particularly in the development of nucleic acid constructs. His work focuses on enhancing the fidelity of protein products expressed in mammalian host cells.
Latest Patents
Mark Albrecht holds 1 patent related to a humanized nucleic acid construct derived from the protective antigen (PA) gene. This invention involves a method of modifying the gene to improve the structural fidelity of the expressed protein product. The humanized gene and its production method are particularly useful in nucleic acid-based vaccine formulations.
Career Highlights
Albrecht is currently associated with the United States Navy, where he contributes his expertise in biotechnology. His work has implications for vaccine development and other applications in the medical field.
Collaborations
Mark Albrecht has worked alongside Stanley Goldman, furthering research and innovation in their respective fields.
Conclusion
Mark Albrecht's contributions to biotechnology, particularly through his patent on nucleic acid constructs, highlight his role as an innovator in the industry. His work continues to influence advancements in vaccine technology and protein expression.